6-Chloro-2-hexanone

We are 6-Chloro-2-hexanone CAS:10226-30-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:6-Chloro-2-hexanone
CAS.NO:10226-30-9
Synonyms:6-Chloro-2-hexanone
1-Chloro-5-hexanone
Chlorohexanone
6-Chloro-2-hexanol
Molecular Formula:C6H11ClO
Molecular Weight:134.60400
 
Physical and Chemical Properties:
Density:1.02
Boiling point:85.5-86.5ºC
Flash point:195°F
Index of Refraction:1.4435
 
Specification:
Appearance:Light or dark yellow liquid
Assay:≥97.0%
Moisture:≤1.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Pentoxifylline

6-Chloro-2-hexanone


Related News: INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.1,3-dicyclohexylcarbodiimide CAS:538-75-0 INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.675-20-7 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.6-cloro-2-fluoropurina CAS:1651-29-2 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.

Related Products
Product Name
4-Bromo-9,9-dimethyl-9H-fluorene View Details
CAS:2627-95-4 Evonik Degussa CD 6210 View Details
Decafluorobiphenyl Cas:434-90-2 View Details
1-octyl-3-methylimidazolium hexafluorophosphate manufacturer 3-Cyanobenzylchloride manufacturer 1-butyl-3-methylimidazolium trifluoromethansulfonate manufacturer Dibutyl maleate manufacturer DL-Tryptophan manufacturer